Hepatocyte growth factor signaling pathway inhibits cholesterol 7α-hydroxylase and bile acid synthesis in human hepatocytes
Open Access
- 8 October 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 46 (6), 1993-2002
- https://doi.org/10.1002/hep.21878
Abstract
Bile acid synthesis in the liver is regulated by the rate-limiting enzyme cholesterol 7α-hydroxylase (CYP7A1). Transcription of the CYP7A1 gene is inhibited by bile acids and cytokines. The rate of bile acid synthesis is reduced immediately after partial hepatectomy and during the early stage of liver regeneration. Hepatocyte growth factor (HGF) released from stellate cells activates a receptor tyrosine kinase c-Met, in hepatocytes and stimulates signaling pathways that regulate cell growth, proliferation, and apoptosis. This study demonstrated that HGF strongly and rapidly repressed CYP7A1 mRNA expression and the rate of bile acid synthesis in primary human hepatocytes. HGF rapidly induced c-Jun and small heterodimer partner mRNA and protein expression and increased phosphorylation of ERK1/2, JNK, and c-Jun. Specific inhibitors of protein kinase C, extracellular signal–regulated kinase 1/2 (ERK1/2), and c-Jun N-terminal kinase (JNK) blocked HGF inhibition of CYP7A1 expression. Knockdown of c-Met by small interfering RNA resulted in a significant increase in CYP7A1 and blocked HGF inhibition of CYP7A1 mRNA expression. Chromatin immunoprecipitation assays showed that HGF induced recruitment of c-Jun and small heterodimer partner (SHP) but reduced recruitment of the coactivators peroxisome proliferators activated receptor ρ coactivator 1α (PGC-1α) and cAMP response element binding protein (CREB)–binding protein (CBP) to chromatin. Conclusion: This study demonstrated that HGF is a novel regulator of CYP7A1 and bile acid synthesis in human hepatocytes and may protect hepatocytes from accumulating toxic bile acids and developing intrahepatic cholestasis during the early stage of liver regeneration. (HEPATOLOGY 2007.)Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 58379, DK44442, DK92310 (LTPADS))
This publication has 33 references indexed in Scilit:
- Gene expression profiles of drug‐metabolizing enzymes and transporters with an overexpression of hepatocyte growth factorLiver International, 2006
- Bile acids and cytokines inhibit the human cholesterol 7α-hydroxylase gene via the JNK/c-jun pathway in human liver cellsHepatology, 2006
- Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver RegenerationScience, 2006
- Glucagon and cAMP inhibit cholesterol 7α-hydroxylase (CYP7a1) gene expression in human hepatocytes: Discordant regulation of bile acid synthesis and gluconeogenesisHepatology, 2005
- The orphan nuclear receptor SHP is involved in monocytic differentiation, and its expression is increased by c-JunJournal of Leukocyte Biology, 2004
- Hepatocyte growth factor/scatter factor‐induced intracellular signallingInternational Journal of Experimental Pathology, 2000
- Lipopolysaccharide potentiates the effect of hepatocyte growth factor on hepatocyte replication in rats by augmenting AP-1 activityHepatology, 1999
- Hepatic bile acid synthesis and DNA synthetic rate after partial hepatectomyBritish Journal of Surgery, 1996
- Hepatocyte growth factor (HGF) mediates the sustained formation of 1,2‐diacylglycerol via phosphatidylcholine—phospholipase C in cultured rat hepatocytesFEBS Letters, 1992
- Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized ratsBiochemical and Biophysical Research Communications, 1984